Invited review: Aging and sarcopenia.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanisms and epidemiology of sarcopenia without systematic search methodology.
PubMed 12970377 · doi:10.1152/japplphysiol.00347.2003
What was done
This invited narrative review synthesized existing evidence on age-related loss of skeletal muscle mass and strength (sarcopenia), examining neuromuscular, hormonal, nutritional, and inflammatory mechanisms, epidemiological prevalence, and intervention strategies.
What was found
By the seventh and eighth decades of life, maximal voluntary contractile strength decreases on average by 20-40% for both men and women across proximal and distal muscles. Reduced muscle mass accounts for the majority of strength loss. Sarcopenia prevalence may reach up to 30% for individuals aged 60 and older. Contributing mechanisms include loss of skeletal muscle fibers secondary to reduced motoneuron counts, reduced physical activity, altered hormonal status, lower total caloric and protein intake, inflammatory mediators, and impaired protein synthesis.
Why it matters
It emphasizes sarcopenia as a primary driver of functional disability in aging populations and highlights resistance exercise, nutritional approaches, and pharmacological interventions as key preventive targets.
Limits
As an invited narrative review, the paper provides no systematic literature search, quantitative meta-analysis, or quality assessment of included studies. The abstract presents general estimates without specific sample sizes, effect bounds, or primary human trial datasets.
Cited by
- context During aging, distal muscles furthest from the midline (such as grip, calf, and foot muscles) degenerate first at the muscle, motor neuron, and spinal levels.